Finance

Beta
Lists
002393:SHE
Tianjin Lisheng Pharmaceutical Co Ltd
CN¥14.06
-2.36%
(-0.34) 1D
Jun 8, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002393...
Open
CN¥14.30
High
CN¥14.45
Low
CN¥13.89
Mkt. cap
4.45B
Avg. vol.
3.03M
Volume
2.21M
Dividend
5.33%
Quarterly dividend
CN¥0.19
Ex-dividend date
Apr 28, 2026
P/E ratio
10.39
52-wk high
CN¥23.98
52-wk low
CN¥13.89
EPS
CN¥1.35
Shares outstanding
308.96M
No. of employees
2K
Open
CN¥14.30
High
CN¥14.45
Low
CN¥13.89
Mkt. cap
4.45B
Avg. vol.
3.03M
Volume
2.21M
Dividend
5.33%
Quarterly dividend
CN¥0.19
Ex-dividend date
Apr 28, 2026
P/E ratio
10.39
52-wk high
CN¥23.98
52-wk low
CN¥13.89
EPS
CN¥1.35
Shares outstanding
308.96M
No. of employees
2K
News stories
From sources across the web
About Tianjin Lisheng Pharmaceutical Co Ltd
CEO-
Employees1.6K
Founded1951
Headquarters-
SectorPharmaceutical industry
Websitelishengpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
361.67M
275.77M
384.73M
332.28M
Cost of goods sold
162.55M
107.04M
220.06M
148.48M
Cost of revenue
162.55M
107.04M
220.06M
148.48M
Research and development expenses
28.20M
31.35M
22.62M
19.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
149.25M
92.87M
135.01M
108.37M
Operating expense
182.86M
127.11M
165.03M
132.42M
Total operating expenses
345.41M
234.15M
385.09M
280.90M
Operating income
16.26M
41.62M
-356.56K
51.38M
Other non operating income
-398.76K
-13.24M
13.61M
-7.05K
EBT including unusual items
334.09M
31.57M
22.59M
62.31M
EBT excluding unusual items
346.45M
34.06M
20.55M
61.02M
Income tax expense
45.32M
2.62M
-25.85M
9.24M
Effective tax rate
13.57%
8.30%
-114.43%
14.83%
Other operating expenses
5.55M
3.04M
7.49M
4.08M
Net income
287.65M
27.82M
45.54M
51.88M
Net profit margin
79.53%
10.09%
11.84%
15.61%
Earnings per share
-
-
-
-
Interest and investment income
331.53M
6.29M
7.66M
10.11M
Interest expense
-924.91K
-626.76K
-342.54K
-456.05K
Net interest expenses
330.60M
5.67M
7.31M
9.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
34.76M
60.86M
18.04M
69.77M
Gain or loss from assets sale
2.24M
-2.24M
-249.61K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer